Paralel Advisors LLC Purchases New Stake in Option Care Health, Inc. $OPCH

Paralel Advisors LLC acquired a new position in Option Care Health, Inc. (NASDAQ:OPCH) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 85,835 shares of the company’s stock, valued at approximately $1,800,000. Paralel Advisors LLC owned approximately 0.06% of Option Care Health as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also recently made changes to their positions in the stock. Wedmont Private Capital purchased a new position in Option Care Health in the second quarter valued at about $250,000. Raiffeisen Bank International AG grew its holdings in shares of Option Care Health by 92.3% in the 2nd quarter. Raiffeisen Bank International AG now owns 250,000 shares of the company’s stock worth $5,330,000 after acquiring an additional 120,000 shares during the period. Nykredit A S purchased a new position in Option Care Health in the 2nd quarter valued at approximately $56,000. Public Employees Retirement System of Ohio acquired a new position in Option Care Health during the second quarter worth $66,000. Finally, Bank of New York Mellon Corp purchased a new stake in Option Care Health during the second quarter worth $19,600,000. Institutional investors and hedge funds own 98.05% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have recently weighed in on OPCH. Deutsche Bank Aktiengesellschaft restated a “hold” rating and issued a $24.00 price target (down from $26.00) on shares of Option Care Health in a research report on Thursday, July 30th. Weiss Ratings cut shares of Option Care Health from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Thursday, August 27th. Zacks Research raised shares of Option Care Health from a “strong sell” rating to a “hold” rating in a report on Monday, July 6th. Stephens reiterated an “equal weight” rating and issued a $24.00 price target (down from $30.00) on shares of Option Care Health in a research report on Friday, July 17th. Finally, UBS Group reissued a “buy” rating on shares of Option Care Health in a research note on Tuesday, June 16th. Seven research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, Option Care Health currently has a consensus rating of “Hold” and an average price target of $29.92.

Option Care Health Price Performance

Option Care Health stock opened at $24.21 on Monday. The firm’s 50-day moving average is $22.80 and its two-hundred day moving average is $24.79. The company has a debt-to-equity ratio of 0.91, a current ratio of 1.47 and a quick ratio of 0.98. The stock has a market capitalization of $3.63 billion, a P/E ratio of 18.20, a P/E/G ratio of 1.40 and a beta of 0.61. Option Care Health, Inc. has a 12-month low of $18.01 and a 12-month high of $36.80.

Option Care Health (NASDAQ:OPCH) last announced its quarterly earnings data on Wednesday, July 29th. The company reported $0.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.43 by $0.02. The business had revenue of $1.44 billion for the quarter, compared to the consensus estimate of $1.42 billion. Option Care Health had a net margin of 3.68% and a return on equity of 18.74%. The company’s quarterly revenue was up 1.9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.41 earnings per share. Option Care Health has set its FY 2026 guidance at 1.850-1.920 EPS. Equities analysts predict that Option Care Health, Inc. will post 1.69 earnings per share for the current year.

About Option Care Health

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.